Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
other: experimental result on similar substance
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study well documented, meets generally accepted scientific principles, acceptable for assessment.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2004
Report date:
2004

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
GLP compliance:
not specified
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Reference substance name:
Sodium 4-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate
EC Number:
211-199-0
EC Name:
Sodium 4-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate
Cas Number:
633-96-5
Molecular formula:
C16H12N2O4S.Na
IUPAC Name:
Sodium 4-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate
Test material form:
solid: particulate/powder

In vivo test system

Test animals

Species:
mouse
Strain:
CBA
Sex:
female

Study design: in vivo (LLNA)

Vehicle:
other: mixture ethanol/water (50/50)

Results and discussion

In vivo (LLNA)

Resultsopen allclose all
Parameter:
other: Migrated information from in vivo LLNA study
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 28.0. Group: test group. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No systemic symptoms were observed..
Parameter:
SI
Remarks on result:
other: 2.5%: 1.10 5%: 1.10 10%: 1.59
Parameter:
other: disintegrations per minute (DPM)
Remarks on result:
other: Per Node: Negative control: 43.43 2.5%: 47.90 5%: 47.88 10%: 69.20 Per group: Negative control: 347.47 2.5%: 383.17 5%: 383.04 10%: 553.59

Any other information on results incl. tables

No clinical signs, no mortality and no noteworthy increase in ear thickness were observed during the study.

Conceming the lymphoproliferative response, the incorporation of tritiated methyl thymidine in the treated groups was similar to that ofthe vehicle control group.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Remarks:
Migrated information
Conclusions:
According to EEC (European Economie Community) and CLP classification the tested substance Acid Orange 7 is not a skin sensitizer.
Executive summary:

The purpose of this skin sensitization study was to assess the allergenic potential of similar substance 01 when administered to the skin of CBA mice following OECD 429, murine local lymph assay. Based on the results, the tested item should not be considered as skin sensitizer.